Skip to main content

Table 2 Clinical outcome of patients after two years of ACI. Lysholm score (65% cutoff) after two years was used to divide patients in success and failure group

From: In vitro chondrogenic potency of surplus chondrocytes from autologous transplantation procedures does not predict short-term clinical outcomes

Source

Age-ranges

Gender

Defect (cm2)

VAS

KOOS

Lysholm

Pre

2 yr

Pre

2 yr

Pre

2 yr

Success group (> 65% Lysholm)

 Donor 1

19–55

M

2.25

40

3

43.5

82.7

55

90

 Donor 2

M

3

40

12

68.5

82.1

69

90

 Donor 3

M

4.6

50

10

71.4

83.9

56

86

 Donor 4

M

9.75

62

10

62.5

76.9

52

83

 Donor 5

F

5.2

31

34

78

82.7

64

78

 Donor 6

F

3.6

51

14

68.3

73.8

59

74

 Donor 7

F

6

48

51

58.3

70.8

57

69

 Donor 8

M

21.5

17

4

72.6

84.8

50

69

 Donor 9

M

2.4

67

35

38.7

71.4

58

68

Failure group (< 65% Lysholm)

 Donor 10

31–52

F

1.82

50

69

32.1

54.8

56

62

 Donor 11

M

5

51

37

82.7

52.4

64

56

 Donor 12

M

3

30

56

36.3

47.6

56

49

 Donor 13

F

3.1

60

73

68.5

47.6

55

47

 Donor 14

M

1.2

74

76

44

35.7

41

38